Key points are not available for this paper at this time.
Diltiazem, a commonly prescribed ventricular rate-control medication for patients with atrial fibrillation, inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation.
Ray et al. (Mon,) studied this question.